Mersana Therapeutics Inc. [MRSN] Sees 247 Share Insider Sell From VP, Controller Mandelia Ashish
On Jan. 04, Mandelia Ashish divested U.S. $6,610 in shares of Mersana Therapeutics Inc.. The VP, Controller sold 247 shares at a price per share of $26.76. The transaction decreased this specific insider’s holdings to 0 shares worth around $0.0 at present. Stifel launched its Mersana Therapeutics Inc. [MRSN] rating to the equivalent of a […]
